|
Identifying the high risk group in stage pT1bN0 cutaneous melanoma. |
|
|
Honoraria - Pierre Fabre Médicament |
Travel, Accommodations, Expenses - Regeneron |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bristol-Myers Squibb; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Sanofi |
Consulting or Advisory Role - Amgen; AstraZeneca; Blueprint Medicines; Bristol-Myers Squibb; MSD; Novartis; Philogen; Pierre Fabre |
Speakers' Bureau - Novartis; Pfizer; Pierre Fabre |
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Orphan Europe; Pierre Fabre |